C12N 15/87 Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Introduced: January 1990
Last revised: January 2006
Full Title
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor > Recombinant DNA-technology > Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Classification Context
- Section:
- CHEMISTRY; METALLURGY
- Class:
- BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- Subclass:
- MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
Filing statistics
IPC C12N 15/87 belongs to the parent subclass C12N, which recorded 650,624 patent applications worldwide between 2013 and 2023. Annual filings grew from 43,581 in 2013 to 68,426 in 2023 (+57%), peaking at 74,521 applications in 2022. The most active applicants in class C12 are CHINESE ACADEMY OF SCIENCES (10,330 applications), HARVARD UNIVERSITY (7,308 applications) and UNIVERSITY OF CALIFORNIA (6,383 applications).
Source: EPO PATSTAT, worldwide filings
4 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12N 15/873 Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N 15/88 using microencapsulation, e.g. using liposome vesicle
- C12N 15/89 using microinjection
- C12N 15/9 Stable introduction of foreign DNA into chromosome
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- CHINESE ACADEMY OF SCIENCES 10,330
- HARVARD UNIVERSITY US 7,308
- UNIVERSITY OF CALIFORNIA US 6,383
- JIANGNAN UNIVERSITY 5,144
- MONSANTO TECHNOLOGY US 4,121
- PIONEER HI-BRED INTERNATIONAL US 3,630
- REGENERON PHARMACEUTICALS US 3,515
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 3,499
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 3,371
- CJ CHEILJEDANG CORPORATION KR 3,361